Header Logo

Joel Block

Concepts (641)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteoarthritis, Knee
37
2022
373
6.910
Why?
Lupus Erythematosus, Systemic
35
2023
189
6.210
Why?
Osteoarthritis
22
2021
326
5.460
Why?
Arthritis, Rheumatoid
22
2021
258
3.950
Why?
Quality of Life
19
2023
632
2.600
Why?
Knee Joint
22
2020
754
2.470
Why?
Humans
176
2023
27185
2.350
Why?
Rheumatology
11
2022
85
2.250
Why?
Creatine Kinase
5
2015
19
1.980
Why?
Myositis
5
2015
33
1.910
Why?
Osteoarthritis, Hip
11
2020
105
1.900
Why?
Pain
16
2022
409
1.880
Why?
Antirheumatic Agents
11
2020
85
1.870
Why?
Arthralgia
5
2019
133
1.800
Why?
Rheumatic Diseases
6
2021
53
1.770
Why?
Female
103
2021
15271
1.760
Why?
Middle Aged
81
2021
9011
1.730
Why?
Severity of Illness Index
25
2019
891
1.720
Why?
Gait
20
2020
411
1.700
Why?
Male
92
2019
14834
1.540
Why?
Surveys and Questionnaires
16
2023
1155
1.530
Why?
Hip Joint
10
2016
545
1.450
Why?
Shoes
5
2016
32
1.420
Why?
Foot Orthoses
5
2020
12
1.380
Why?
Tuberculosis
5
2013
19
1.370
Why?
Chondrosarcoma
23
2008
43
1.370
Why?
Body Image
5
2014
27
1.360
Why?
Adult
64
2019
7886
1.340
Why?
Immunoglobulin G
7
2013
79
1.340
Why?
Immunosuppressive Agents
7
2017
120
1.310
Why?
Antibodies, Monoclonal
7
2017
178
1.270
Why?
Disease Management
3
2021
105
1.250
Why?
Weight-Bearing
16
2014
157
1.240
Why?
Arthritis, Psoriatic
3
2017
14
1.120
Why?
Hyaluronic Acid
4
2022
55
1.110
Why?
Pain Measurement
11
2019
480
1.100
Why?
Arthritis, Infectious
3
2017
50
1.090
Why?
Publishing
3
2023
34
1.060
Why?
Muscle Strength
6
2019
131
1.040
Why?
Ankle Joint
4
2019
43
1.020
Why?
Health Status Indicators
4
2016
70
1.000
Why?
Vibration
5
2018
27
0.990
Why?
Glucocorticoids
4
2021
68
0.980
Why?
Etanercept
8
2017
21
0.960
Why?
Aged
45
2021
9053
0.960
Why?
Lupus Nephritis
2
2021
27
0.950
Why?
Orthotic Devices
6
2020
24
0.940
Why?
Aspartate Aminotransferases
2
2015
14
0.940
Why?
Alanine Transaminase
2
2015
15
0.940
Why?
Rheumatologists
4
2020
15
0.940
Why?
Spondylitis, Ankylosing
3
2010
20
0.930
Why?
Health Status
10
2018
222
0.880
Why?
Radiography
15
2016
622
0.880
Why?
Reproducibility of Results
15
2021
680
0.880
Why?
Lupus Erythematosus, Cutaneous
2
2014
5
0.870
Why?
Pain Management
6
2018
144
0.860
Why?
Proprioception
3
2014
20
0.850
Why?
Bone Density
6
2011
145
0.810
Why?
Duloxetine Hydrochloride
1
2022
9
0.800
Why?
Joints
5
2009
68
0.790
Why?
Exercise Therapy
5
2020
91
0.790
Why?
Data Interpretation, Statistical
2
2021
77
0.770
Why?
Posterior Leukoencephalopathy Syndrome
1
2021
9
0.760
Why?
Biomechanical Phenomena
13
2020
641
0.730
Why?
Cartilage
5
2023
103
0.720
Why?
Periodicals as Topic
1
2021
39
0.720
Why?
Patient Reported Outcome Measures
5
2020
510
0.700
Why?
Platelet-Rich Plasma
1
2022
87
0.700
Why?
Nerve Growth Factor
2
2017
38
0.690
Why?
Treatment Outcome
17
2022
3536
0.690
Why?
Leg
4
2008
50
0.680
Why?
Analgesics
2
2020
79
0.680
Why?
Tumor Necrosis Factor-alpha
6
2008
190
0.680
Why?
Musculoskeletal Pain
1
2020
20
0.670
Why?
Nerve Growth Factors
1
2020
38
0.660
Why?
Research Design
1
2021
185
0.650
Why?
Injections, Intra-Articular
4
2022
93
0.640
Why?
Analgesics, Non-Narcotic
3
2017
17
0.630
Why?
Retrospective Studies
15
2019
3561
0.630
Why?
Cartilage, Articular
5
2021
413
0.610
Why?
Patient Acuity
1
2018
8
0.610
Why?
Bone Neoplasms
13
2008
130
0.590
Why?
Cross-Sectional Studies
11
2019
896
0.580
Why?
Patient Outcome Assessment
2
2014
37
0.570
Why?
Keratan Sulfate
5
2006
15
0.550
Why?
Dermatomyositis
2
2014
12
0.540
Why?
Hepatitis C, Chronic
1
2017
43
0.540
Why?
Practice Guidelines as Topic
2
2020
260
0.530
Why?
Anti-Inflammatory Agents
2
2015
77
0.530
Why?
Walking
3
2008
252
0.520
Why?
Prednisone
2
2015
66
0.490
Why?
Mortality, Premature
1
2015
6
0.490
Why?
Foot
2
2019
44
0.490
Why?
Antibodies, Monoclonal, Humanized
3
2017
87
0.490
Why?
Methylprednisolone
1
2015
19
0.480
Why?
Leadership
1
2016
92
0.480
Why?
United States
11
2020
2056
0.480
Why?
Paracentesis
1
2015
4
0.470
Why?
Adrenal Cortex Hormones
2
2015
112
0.460
Why?
Fluoroscopy
1
2015
48
0.460
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2014
2
0.450
Why?
Psychometrics
9
2018
220
0.450
Why?
Purpura, Thrombotic Thrombocytopenic
2
2005
10
0.440
Why?
Fructose-Bisphosphate Aldolase
1
2014
3
0.440
Why?
Acute Kidney Injury
1
2014
37
0.430
Why?
Patient Education as Topic
1
2014
130
0.430
Why?
Somatosensory Disorders
2
2018
11
0.420
Why?
Vasculitis
2
2009
26
0.410
Why?
Disease Progression
10
2013
670
0.400
Why?
Dermatology
1
2012
6
0.400
Why?
Diagnostic Self Evaluation
1
2012
14
0.400
Why?
Risk Factors
10
2021
2324
0.400
Why?
Synovial Fluid
5
2011
92
0.400
Why?
Receptors, Tumor Necrosis Factor
7
2013
27
0.400
Why?
Caregivers
1
2015
196
0.390
Why?
Anti-Inflammatory Agents, Non-Steroidal
4
2006
110
0.390
Why?
Arthritis, Experimental
3
2019
49
0.380
Why?
Isoniazid
2
2009
3
0.370
Why?
Touch
2
2008
8
0.370
Why?
Methotrexate
2
2009
38
0.370
Why?
Range of Motion, Articular
7
2019
708
0.360
Why?
Pilot Projects
4
2014
417
0.340
Why?
Benchmarking
1
2010
32
0.340
Why?
Sensory Thresholds
4
2012
23
0.340
Why?
Quadriceps Muscle
1
2010
34
0.340
Why?
Knee
1
2010
45
0.340
Why?
Hand Joints
2
2020
3
0.340
Why?
Dose-Response Relationship, Drug
6
2015
333
0.330
Why?
Demography
1
2010
73
0.330
Why?
Glucosamine
1
2009
4
0.330
Why?
Transaminases
1
2009
6
0.330
Why?
Income
1
2010
80
0.330
Why?
Proteoglycans
5
1994
133
0.320
Why?
Cohort Studies
7
2019
1894
0.310
Why?
Language
4
2021
63
0.310
Why?
Self Report
6
2023
221
0.310
Why?
Cost of Illness
3
2019
50
0.300
Why?
Biomarkers
5
2017
558
0.300
Why?
Liver
1
2009
148
0.300
Why?
Predictive Value of Tests
6
2019
478
0.290
Why?
Academic Medical Centers
2
2019
133
0.290
Why?
Double-Blind Method
9
2016
403
0.290
Why?
Immunoconjugates
1
2008
7
0.290
Why?
Anthropometry
1
2007
32
0.280
Why?
Scleroderma, Systemic
2
2005
8
0.280
Why?
Joint Deformities, Acquired
1
2007
1
0.280
Why?
Aged, 80 and over
10
2019
4817
0.270
Why?
Reference Values
3
2014
186
0.270
Why?
Tumor Cells, Cultured
15
2004
129
0.260
Why?
Braces
2
2020
23
0.260
Why?
Matrix Metalloproteinase 1
3
2005
6
0.250
Why?
Bone Morphogenetic Proteins
1
2006
69
0.250
Why?
Adalimumab
4
2019
16
0.250
Why?
Body Height
4
2007
35
0.240
Why?
Animals
9
2020
3642
0.240
Why?
Antitubercular Agents
4
2013
12
0.240
Why?
Chondrocytes
6
2007
149
0.240
Why?
Femur Head Necrosis
1
2005
7
0.240
Why?
Cross-Cultural Comparison
4
2013
39
0.240
Why?
Acetabulum
1
2007
229
0.230
Why?
Immunocompromised Host
3
2021
46
0.220
Why?
Polymyositis
2
2014
8
0.220
Why?
Cyclophosphamide
2
2003
49
0.220
Why?
Adaptation, Psychological
2
2015
175
0.220
Why?
Young Adult
7
2015
2014
0.210
Why?
Follow-Up Studies
5
2014
1801
0.210
Why?
Anniversaries and Special Events
1
2023
3
0.210
Why?
Case-Control Studies
3
2014
590
0.210
Why?
Diclofenac
1
2003
3
0.210
Why?
Chi-Square Distribution
3
2014
138
0.210
Why?
Doxorubicin
2
2000
57
0.210
Why?
Time Factors
9
2019
1442
0.200
Why?
Prognosis
6
2019
801
0.200
Why?
Acetaminophen
1
2003
24
0.200
Why?
Glycosaminoglycans
4
1994
20
0.200
Why?
Arthroplasty, Replacement, Hip
4
2005
807
0.200
Why?
Neoplasm Invasiveness
6
2006
94
0.200
Why?
Enzyme Inhibitors
2
2019
116
0.190
Why?
Kidney
1
2003
152
0.190
Why?
Risk Assessment
4
2014
631
0.190
Why?
Socioeconomic Factors
3
2015
302
0.190
Why?
Pneumococcal Infections
1
2021
7
0.190
Why?
Lupus Erythematosus, Discoid
1
2021
10
0.190
Why?
Quality of Health Care
3
2023
102
0.190
Why?
Raynaud Disease
1
2001
1
0.190
Why?
Infliximab
3
2013
17
0.190
Why?
Gene Expression
2
2013
202
0.190
Why?
Gait Disorders, Neurologic
2
2019
133
0.180
Why?
Medication Therapy Management
1
2021
4
0.180
Why?
Radiology, Interventional
1
2021
5
0.180
Why?
Paclitaxel
2
2002
51
0.180
Why?
Coronary Disease
1
2001
51
0.180
Why?
Radiography, Interventional
1
2021
16
0.180
Why?
Tuberculosis, Osteoarticular
1
2000
1
0.180
Why?
Longitudinal Studies
5
2015
1365
0.180
Why?
Gene Expression Profiling
5
2013
142
0.180
Why?
Chicago
4
2019
949
0.180
Why?
Patient Care Planning
1
2021
39
0.180
Why?
Adjuvants, Immunologic
2
2019
15
0.170
Why?
Selenium
1
2000
10
0.170
Why?
Awards and Prizes
1
2000
22
0.170
Why?
Diagnosis, Differential
3
2019
351
0.170
Why?
Adolescent
8
2019
2194
0.170
Why?
Foundations
1
2020
1
0.170
Why?
Mycobacterium Infections
1
2019
2
0.170
Why?
Mycobacterium haemophilum
1
2019
2
0.170
Why?
Mediastinal Diseases
1
2019
4
0.170
Why?
Tuberculin Test
3
2009
9
0.170
Why?
Uveitis, Anterior
1
2019
3
0.160
Why?
Spondylarthropathies
1
2019
4
0.160
Why?
Health Impact Assessment
1
2019
4
0.160
Why?
Artificial Limbs
1
2019
6
0.160
Why?
Azacitidine
1
2019
10
0.160
Why?
Absorptiometry, Photon
4
2011
84
0.160
Why?
Hematoma, Epidural, Cranial
1
1999
4
0.160
Why?
RNA, Messenger
7
2007
310
0.160
Why?
Arthroplasty, Replacement, Knee
2
2003
633
0.160
Why?
Cerebral Palsy
1
2019
7
0.160
Why?
Outpatient Clinics, Hospital
1
2018
15
0.150
Why?
Internship and Residency
1
2022
216
0.150
Why?
Checklist
2
2016
33
0.150
Why?
Delivery of Health Care, Integrated
1
2018
19
0.150
Why?
Observer Variation
1
2018
96
0.150
Why?
Quality Indicators, Health Care
1
2018
31
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2000
246
0.150
Why?
Spinal Cord
1
1999
84
0.150
Why?
Disability Evaluation
3
2019
266
0.150
Why?
Chronic Pain
1
2020
132
0.150
Why?
Retinal Diseases
1
1998
4
0.150
Why?
Antibodies, Antinuclear
2
2017
11
0.150
Why?
Hydroxychloroquine
1
1998
10
0.150
Why?
Hyperalgesia
1
2018
44
0.150
Why?
DNA Methylation
1
2019
163
0.140
Why?
Liver Function Tests
1
2017
21
0.140
Why?
Tenascin
3
2002
4
0.140
Why?
RNA, Small Interfering
3
2007
81
0.140
Why?
Sleep Wake Disorders
1
2019
120
0.140
Why?
Europe
2
2018
57
0.140
Why?
Immunotherapy
2
2008
59
0.140
Why?
Viral Load
1
2017
75
0.140
Why?
Statistics as Topic
1
2017
103
0.140
Why?
Arthroplasty
1
1998
151
0.140
Why?
United Kingdom
2
2010
49
0.140
Why?
Unnecessary Procedures
1
2017
27
0.140
Why?
B-Lymphocytes
3
2019
56
0.140
Why?
Neurosurgical Procedures
1
2019
148
0.140
Why?
Stress, Mechanical
2
2007
157
0.140
Why?
Linear Models
2
2014
245
0.130
Why?
Arthritis, Juvenile
2
2009
7
0.130
Why?
Sex Factors
4
2018
467
0.130
Why?
Mycobacterium tuberculosis
2
2009
17
0.130
Why?
Culture
2
2013
23
0.130
Why?
Drug Therapy, Combination
2
2015
169
0.130
Why?
Lower Extremity
1
2016
38
0.130
Why?
Journalism, Medical
1
2016
2
0.130
Why?
Body Weight
3
2006
135
0.130
Why?
Activities of Daily Living
2
2012
597
0.130
Why?
Apoptosis
3
2013
214
0.130
Why?
Age Factors
2
2012
774
0.130
Why?
Practice Patterns, Physicians'
1
2017
110
0.130
Why?
Fatigue
1
2016
54
0.130
Why?
Safety-net Providers
1
2015
7
0.120
Why?
Pulse Therapy, Drug
1
2015
3
0.120
Why?
Infusions, Intravenous
1
2015
52
0.120
Why?
Metatarsophalangeal Joint
1
2015
5
0.120
Why?
Depression
1
2019
440
0.120
Why?
Movement
3
2006
112
0.120
Why?
Professional-Patient Relations
1
2015
28
0.120
Why?
Cosmetic Techniques
1
2014
5
0.120
Why?
Antigens, Neoplasm
2
2007
41
0.120
Why?
Magnetic Resonance Imaging
3
2007
1132
0.120
Why?
Neoplasm Proteins
2
2007
55
0.120
Why?
Wrist Joint
1
2015
59
0.110
Why?
Immunoglobulin kappa-Chains
1
2014
2
0.110
Why?
Immunoglobulin lambda-Chains
1
2014
2
0.110
Why?
Gene Expression Regulation, Neoplastic
4
2008
121
0.110
Why?
Microscopic Polyangiitis
1
2014
2
0.110
Why?
Churg-Strauss Syndrome
1
2014
2
0.110
Why?
Models, Biological
3
2011
321
0.110
Why?
Interleukin-10
1
2014
19
0.110
Why?
Hospitals, University
2
2012
23
0.110
Why?
Physical Examination
2
2022
116
0.110
Why?
Physicians
2
2015
124
0.110
Why?
Creatinine
1
2014
41
0.110
Why?
Interferon-alpha
1
2014
30
0.110
Why?
Granulomatosis with Polyangiitis
1
2014
11
0.110
Why?
Body Mass Index
3
2006
462
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2013
142
0.110
Why?
Interleukin-6
1
2014
75
0.110
Why?
Combined Modality Therapy
1
2014
305
0.110
Why?
Liver Diseases
1
2014
34
0.110
Why?
Abatacept
2
2017
6
0.110
Why?
Cattle
4
2009
126
0.110
Why?
Cell Transformation, Neoplastic
2
2004
32
0.110
Why?
Renal Dialysis
1
2014
82
0.110
Why?
Cystitis
1
1993
12
0.110
Why?
Latent Tuberculosis
1
2013
2
0.100
Why?
Quebec
1
2013
3
0.100
Why?
Cultural Characteristics
1
2013
20
0.100
Why?
Flow Cytometry
4
2019
111
0.100
Why?
Hospitals, County
1
2012
4
0.100
Why?
Prevalence
3
2019
453
0.100
Why?
Phenotype
5
2004
314
0.100
Why?
Randomized Controlled Trials as Topic
2
2004
292
0.100
Why?
Matched-Pair Analysis
1
2012
30
0.100
Why?
Cell Division
3
2002
83
0.100
Why?
Self-Assessment
1
2012
29
0.100
Why?
Self Concept
1
2012
38
0.100
Why?
Sensation Disorders
1
2012
10
0.100
Why?
Body Dysmorphic Disorders
1
2011
2
0.100
Why?
T-Lymphocytes
2
2013
99
0.100
Why?
Cell Line, Tumor
6
2008
264
0.090
Why?
Canada
3
2018
46
0.090
Why?
Immunoglobulin Light Chains
1
2011
3
0.090
Why?
Incidence
1
2014
758
0.090
Why?
Perception
1
2012
76
0.090
Why?
Oligonucleotide Array Sequence Analysis
3
2008
59
0.090
Why?
Mass Screening
1
2013
172
0.090
Why?
Morphogenesis
1
1991
8
0.090
Why?
Afferent Pathways
1
2010
4
0.090
Why?
Clinical Trials as Topic
2
2017
216
0.090
Why?
Muscle Weakness
1
2010
34
0.090
Why?
Sickness Impact Profile
1
2010
9
0.080
Why?
Teaching
2
2022
52
0.080
Why?
Prospective Studies
4
2011
1777
0.080
Why?
Pressure
1
2010
64
0.080
Why?
Turkey
2
2013
6
0.080
Why?
Acute Disease
1
2010
177
0.080
Why?
Menisci, Tibial
1
2012
173
0.080
Why?
Horses
1
2009
10
0.080
Why?
Anterior Cruciate Ligament Injuries
1
2012
196
0.080
Why?
Social Environment
1
2010
76
0.080
Why?
Cytokines
1
2011
232
0.080
Why?
Cognitive Dysfunction
1
2019
1061
0.080
Why?
Dogs
1
2009
166
0.080
Why?
Administration, Oral
1
2009
110
0.080
Why?
Rabbits
1
2009
180
0.080
Why?
Tendon Injuries
1
2012
203
0.080
Why?
Intervertebral Disc Chemolysis
1
1989
6
0.080
Why?
Educational Status
1
2010
290
0.080
Why?
Extremities
1
2008
27
0.080
Why?
Chordoma
1
2008
9
0.080
Why?
DNA, Neoplasm
3
2004
24
0.080
Why?
Posture
2
2006
63
0.080
Why?
Orthopedic Procedures
1
2012
308
0.070
Why?
Endopeptidases
3
1996
21
0.070
Why?
Postoperative Period
2
2019
334
0.070
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
29
0.070
Why?
Rats
1
2009
660
0.070
Why?
Intervertebral Disc Displacement
1
1989
84
0.070
Why?
Rituximab
1
2008
47
0.070
Why?
Bone Diseases, Developmental
1
2007
1
0.070
Why?
Apoptosis Regulatory Proteins
1
2007
11
0.070
Why?
HLA-A1 Antigen
1
2007
1
0.070
Why?
Recombinant Fusion Proteins
1
2007
30
0.070
Why?
T-Lymphocytes, Cytotoxic
1
2007
23
0.070
Why?
Fibroblast Growth Factor 2
1
2007
11
0.070
Why?
Matrix Metalloproteinase 13
1
2007
19
0.070
Why?
Protein Kinase C-delta
1
2007
10
0.070
Why?
Alternative Splicing
3
2002
21
0.070
Why?
Mitogen-Activated Protein Kinases
1
2007
29
0.070
Why?
Microscopy, Atomic Force
1
2006
5
0.070
Why?
Schizosaccharomyces pombe Proteins
2
1996
2
0.070
Why?
Genes, Tumor Suppressor
2
1996
11
0.070
Why?
Bone Morphogenetic Protein 7
1
2006
30
0.060
Why?
Image Processing, Computer-Assisted
1
2007
164
0.060
Why?
Autoantigens
1
2006
26
0.060
Why?
Carrier Proteins
2
1996
100
0.060
Why?
Exercise Test
1
2006
123
0.060
Why?
Emotions
2
2017
72
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
2001
29
0.060
Why?
ADAMTS13 Protein
1
2005
5
0.060
Why?
Metalloendopeptidases
1
2005
11
0.060
Why?
Child
5
2019
1298
0.060
Why?
ADAM Proteins
1
2005
41
0.060
Why?
Cells, Cultured
5
2007
524
0.060
Why?
Hypoxia
1
2004
32
0.060
Why?
Abstracting and Indexing as Topic
1
2004
1
0.060
Why?
MEDLINE
1
2004
5
0.060
Why?
Signal Transduction
1
2007
448
0.060
Why?
Therapeutic Irrigation
1
2004
57
0.060
Why?
Terminology as Topic
1
2004
32
0.060
Why?
Alcoholism
1
2005
70
0.060
Why?
Vascular Endothelial Growth Factor A
1
2004
78
0.060
Why?
Kidney Diseases
1
2005
71
0.060
Why?
Biopsy, Fine-Needle
1
2004
62
0.060
Why?
Tibia
1
2006
245
0.060
Why?
RNA, Antisense
1
2003
2
0.050
Why?
Matrix Metalloproteinase Inhibitors
1
2003
6
0.050
Why?
Protein-Tyrosine Kinases
1
2003
17
0.050
Why?
Transcription Factors
1
2004
168
0.050
Why?
Disease Models, Animal
2
2019
601
0.050
Why?
Extracellular Matrix
3
2008
51
0.050
Why?
Translations
2
2013
9
0.050
Why?
Tuberculosis, Gastrointestinal
1
2003
2
0.050
Why?
Peritonitis
1
2003
17
0.050
Why?
Sample Size
1
2003
18
0.050
Why?
Telomerase
1
2002
10
0.050
Why?
Femur Head
1
2003
69
0.050
Why?
Factor Analysis, Statistical
2
2013
55
0.050
Why?
Biopsy
1
2003
200
0.050
Why?
Tacrolimus
1
2002
15
0.050
Why?
Treatment Failure
1
2003
160
0.050
Why?
Mice
2
2019
1408
0.050
Why?
Patient Acceptance of Health Care
1
2023
77
0.050
Why?
Internal Medicine
1
2022
31
0.050
Why?
Vaccination
1
2021
35
0.050
Why?
Fibronectins
1
2001
19
0.050
Why?
Collagen
2
2008
86
0.050
Why?
Cyclin-Dependent Kinases
1
2001
5
0.040
Why?
Alendronate
1
2001
7
0.040
Why?
Retinoblastoma Protein
1
2001
11
0.040
Why?
Ethambutol
1
2000
1
0.040
Why?
Mycobacterium
1
2000
1
0.040
Why?
Pyrazinamide
1
2000
1
0.040
Why?
Streptomycin
1
2000
1
0.040
Why?
Rifampin
1
2000
3
0.040
Why?
Adaptation, Physiological
1
2001
47
0.040
Why?
Proto-Oncogene Proteins
1
2001
35
0.040
Why?
Plasmapheresis
2
1999
13
0.040
Why?
Lung Diseases, Interstitial
1
2000
6
0.040
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2000
2
0.040
Why?
Spinal Fractures
1
2001
43
0.040
Why?
RNA, Neoplasm
1
2000
13
0.040
Why?
Consensus
1
2021
90
0.040
Why?
England
1
2020
16
0.040
Why?
Genetic Variation
1
2001
98
0.040
Why?
DNA Fragmentation
1
2000
5
0.040
Why?
Cell Size
1
2000
7
0.040
Why?
Drug Screening Assays, Antitumor
1
2000
11
0.040
Why?
Amino Acids
1
2000
19
0.040
Why?
Biological Transport
1
2000
39
0.040
Why?
Ankle
1
2020
23
0.040
Why?
Universities
1
2020
39
0.040
Why?
Intestinal Neoplasms
1
2000
13
0.040
Why?
Evidence-Based Medicine
1
2021
162
0.040
Why?
Myocardial Infarction
1
2001
133
0.040
Why?
Clinical Competence
1
2022
210
0.040
Why?
Staphylococcal Protein A
1
1999
2
0.040
Why?
ATP-Binding Cassette Transporters
1
1999
16
0.040
Why?
Cell Membrane
1
2000
89
0.040
Why?
Lactones
1
1999
9
0.040
Why?
Colonic Neoplasms
1
2000
57
0.040
Why?
Polymerase Chain Reaction
3
2004
121
0.040
Why?
Antibiotics, Antineoplastic
1
1999
17
0.040
Why?
Cyclooxygenase Inhibitors
1
1999
27
0.040
Why?
Delayed Diagnosis
1
2019
11
0.040
Why?
Analysis of Variance
1
2000
258
0.040
Why?
Chromatin Immunoprecipitation
1
2019
22
0.040
Why?
Gene Silencing
1
2019
24
0.040
Why?
Lymph Nodes
1
2019
72
0.040
Why?
Ovarian Neoplasms
1
2000
79
0.040
Why?
Quadriplegia
1
1999
8
0.040
Why?
Asia
1
2018
9
0.040
Why?
Femur Neck
1
1999
21
0.040
Why?
Chromatography, Ion Exchange
3
1994
6
0.040
Why?
Mentors
1
2019
37
0.040
Why?
Appointments and Schedules
1
2018
13
0.040
Why?
Liver Neoplasms
1
2000
103
0.040
Why?
Morbidity
1
2018
53
0.040
Why?
Prostatic Neoplasms
1
2000
114
0.040
Why?
Sex Distribution
1
2018
78
0.040
Why?
Workload
1
2018
29
0.040
Why?
Blotting, Western
2
2013
149
0.040
Why?
Up-Regulation
2
2013
174
0.040
Why?
Electronic Health Records
1
2019
74
0.040
Why?
Autoimmune Diseases
1
2019
44
0.040
Why?
Faculty, Medical
1
2019
44
0.040
Why?
Hip
1
1999
67
0.040
Why?
Biomedical Research
1
2019
57
0.040
Why?
Antineoplastic Agents
1
2000
202
0.040
Why?
Databases, Factual
1
2019
350
0.040
Why?
Blood Sedimentation
1
2017
53
0.030
Why?
Diathermy
1
1997
1
0.030
Why?
Health Care Surveys
1
2017
64
0.030
Why?
DNA Primers
3
2004
51
0.030
Why?
Osteonecrosis
1
2017
16
0.030
Why?
Prosthesis Design
1
2019
488
0.030
Why?
Drug Evaluation, Preclinical
1
2017
30
0.030
Why?
Immunohistochemistry
3
2003
374
0.030
Why?
Physical Therapy Modalities
1
1997
74
0.030
Why?
Illinois
1
2017
250
0.030
Why?
Mental Health
1
2017
109
0.030
Why?
Independent Living
1
2019
322
0.030
Why?
Chromatography, Gel
2
1994
8
0.030
Why?
Sleep Initiation and Maintenance Disorders
1
2017
108
0.030
Why?
Breast Neoplasms
1
2000
411
0.030
Why?
Multivariate Analysis
1
2016
332
0.030
Why?
Software
1
2015
61
0.030
Why?
Exercise
1
2019
451
0.030
Why?
Lung Neoplasms
1
2000
551
0.030
Why?
Enzyme Activation
2
2007
118
0.030
Why?
Sleep
1
2017
317
0.030
Why?
Goals
1
2014
40
0.030
Why?
Arthrography
2
2006
29
0.030
Why?
Clone Cells
2
1991
11
0.030
Why?
Cell Movement
2
2005
81
0.030
Why?
Transcription, Genetic
2
2007
107
0.030
Why?
Aging
1
2003
1549
0.030
Why?
Aurora Kinases
1
2013
3
0.030
Why?
Transfection
2
2003
121
0.030
Why?
Mice, Inbred DBA
1
2013
17
0.030
Why?
Polyarteritis Nodosa
1
1993
1
0.030
Why?
Necrosis
1
1993
26
0.030
Why?
Inflammation
1
2015
273
0.030
Why?
Latin America
1
2013
5
0.030
Why?
Mice, Inbred BALB C
1
2013
101
0.030
Why?
Histones
1
2013
32
0.030
Why?
Philippines
1
2013
4
0.030
Why?
Phosphorylation
1
2013
148
0.030
Why?
Protein Kinase Inhibitors
1
2013
55
0.030
Why?
Hemorrhage
1
1993
85
0.030
Why?
Cell Adhesion
2
2003
31
0.030
Why?
Epigenesis, Genetic
1
2013
83
0.030
Why?
Cell Proliferation
1
2013
179
0.020
Why?
Piperazines
1
2013
86
0.020
Why?
Chondroitin Lyases
1
1992
1
0.020
Why?
Chymotrypsin
1
1992
2
0.020
Why?
Trypsin
1
1992
4
0.020
Why?
Electrochemistry
1
1992
42
0.020
Why?
Denmark
1
2012
10
0.020
Why?
Sweden
1
2012
9
0.020
Why?
Feedback
1
2012
32
0.020
Why?
Sensitivity and Specificity
1
2013
481
0.020
Why?
Base Sequence
2
2002
108
0.020
Why?
Metabolism
1
2011
6
0.020
Why?
Fluorescent Antibody Technique
1
1991
56
0.020
Why?
Chondroitin Sulfates
1
1991
6
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
90
0.020
Why?
Cell Line
1
1991
272
0.020
Why?
Tissue Donors
1
2011
79
0.020
Why?
Drug Resistance, Neoplasm
2
2002
68
0.020
Why?
Femoral Neoplasms
1
1990
4
0.020
Why?
Self-Examination
1
2009
3
0.020
Why?
Chymopapain
1
1989
5
0.020
Why?
Chromosome Aberrations
2
2001
17
0.020
Why?
X-Linked Inhibitor of Apoptosis Protein
1
2007
1
0.020
Why?
bcl-X Protein
1
2007
5
0.020
Why?
Radiation Tolerance
1
2007
6
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
20
0.020
Why?
Antigen Presentation
1
2007
14
0.020
Why?
Epitopes
1
2007
44
0.020
Why?
Arteries
1
2007
14
0.020
Why?
Cell Survival
1
2007
119
0.020
Why?
Viscosity
1
2006
10
0.020
Why?
Interleukin-1beta
1
2007
52
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2007
34
0.020
Why?
Elasticity
1
2006
31
0.020
Why?
Interferon-gamma
1
2007
83
0.020
Why?
Actins
1
2006
35
0.020
Why?
Single-Blind Method
1
2006
101
0.020
Why?
Purine-Nucleoside Phosphorylase
2
1996
2
0.020
Why?
Chromosome Banding
2
1996
4
0.020
Why?
Chromosomes, Human, Pair 9
2
1996
7
0.020
Why?
Ploidies
2
1996
8
0.020
Why?
Risk
2
2004
206
0.020
Why?
Sequence Deletion
2
1996
16
0.020
Why?
Models, Anatomic
1
2006
38
0.020
Why?
Cognition
1
2014
1334
0.020
Why?
Gene Targeting
1
2005
10
0.010
Why?
Culture Media, Conditioned
1
2005
19
0.010
Why?
Collagen Type I
1
2005
19
0.010
Why?
Genes, myc
1
2004
8
0.010
Why?
Genome
1
2004
10
0.010
Why?
Gene Dosage
1
2004
19
0.010
Why?
Cell Culture Techniques
1
2004
34
0.010
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2004
10
0.010
Why?
Neovascularization, Pathologic
1
2004
36
0.010
Why?
Adverse Drug Reaction Reporting Systems
1
2004
4
0.010
Why?
Information Storage and Retrieval
1
2004
2
0.010
Why?
Culture Techniques
2
1994
19
0.010
Why?
Cell Differentiation
1
2004
135
0.010
Why?
Focal Adhesion Kinase 1
1
2003
1
0.010
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2003
2
0.010
Why?
Integrins
1
2003
13
0.010
Why?
Collagen Type II
1
2003
22
0.010
Why?
Collagenases
1
2003
15
0.010
Why?
Protein Structure, Tertiary
1
2003
62
0.010
Why?
Down-Regulation
1
2003
101
0.010
Why?
Drug Administration Schedule
1
2003
160
0.010
Why?
Biopsy, Needle
1
2003
103
0.010
Why?
Microscopy, Phase-Contrast
1
2002
6
0.010
Why?
Chondroma
1
2002
6
0.010
Why?
Telomere
1
2002
8
0.010
Why?
Prednisolone
1
2002
8
0.010
Why?
Hospitals, Community
1
2002
12
0.010
Why?
Protein Isoforms
1
2002
44
0.010
Why?
Drug Resistance
1
2002
47
0.010
Why?
Osteosarcoma
1
2002
40
0.010
Why?
K562 Cells
1
2002
4
0.010
Why?
Blotting, Northern
1
2002
22
0.010
Why?
Plasma Exchange
1
1982
12
0.010
Why?
Amino Acid Sequence
1
2002
155
0.010
Why?
Molecular Sequence Data
1
2002
195
0.010
Why?
Binding Sites
1
2001
72
0.010
Why?
Injections, Intralesional
1
2001
32
0.010
Why?
Cyclin-Dependent Kinase 4
1
2001
3
0.010
Why?
Genes, p16
1
2001
4
0.010
Why?
Placebos
1
2001
65
0.010
Why?
Bone Resorption
1
2001
84
0.010
Why?
Multidrug Resistance-Associated Proteins
1
1999
1
0.010
Why?
Drug Resistance, Multiple
1
1999
12
0.010
Why?
Sulfones
1
1999
20
0.010
Why?
Survival Rate
1
2001
344
0.010
Why?
Reoperation
1
2002
923
0.010
Why?
Postoperative Complications
1
2003
927
0.010
Why?
Interferons
1
1996
9
0.010
Why?
Chromosome Disorders
1
1996
14
0.010
Why?
In Situ Hybridization, Fluorescence
1
1996
37
0.010
Why?
Fees, Medical
1
1975
1
0.010
Why?
Public Opinion
1
1975
5
0.010
Why?
Financing, Organized
1
1975
8
0.010
Why?
Centrifugation, Density Gradient
1
1994
4
0.010
Why?
Cesium
1
1994
13
0.010
Why?
Molecular Weight
1
1994
26
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
27
0.010
Why?
Culture Media
1
1994
31
0.010
Why?
Chlorides
1
1994
25
0.010
Why?
Immunoassay
1
1994
38
0.010
Why?
Hexuronic Acids
1
1994
6
0.010
Why?
Glucuronic Acid
1
1994
6
0.010
Why?
Tritium
1
1994
8
0.010
Why?
Sulfur Radioisotopes
1
1994
8
0.010
Why?
Sulfates
1
1994
4
0.010
Why?
Alginates
1
1994
7
0.010
Why?
Proline
1
1994
10
0.010
Why?
Orchiectomy
1
1994
4
0.010
Why?
Delivery of Health Care
1
1975
144
0.010
Why?
Gels
1
1994
12
0.010
Why?
Peptide Fragments
1
1994
75
0.010
Why?
Lumbar Vertebrae
1
1999
391
0.010
Why?
Microscopy, Electron
1
1994
63
0.010
Why?
Plasminogen
1
1982
1
0.000
Why?
Hemostasis
1
1982
11
0.000
Why?
Antithrombin III
1
1982
4
0.000
Why?
Blood Coagulation Factors
1
1982
20
0.000
Why?
Thrombosis
1
1982
56
0.000
Why?
New York
1
1975
10
0.000
Why?
Financing, Government
1
1975
9
0.000
Why?
Attitude
1
1975
34
0.000
Why?
Consumer Behavior
1
1975
23
0.000
Why?
Block's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (641)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_